Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China flag China · Delayed Price · Currency is CNY
271.48
+2.10 (0.78%)
At close: Mar 20, 2026

SHA:688506 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
111,220133,40076,88456,100--
Market Cap Growth
51.27%73.51%37.05%---
Enterprise Value
108,834131,01373,45856,019--
Last Close Price
269.38323.10191.73139.90--
PE Ratio
--20.74---
Forward PE
--71.91---
PS Ratio
44.1352.9313.2099.85--
PB Ratio
15.5118.6019.79369.39--
P/TBV Ratio
15.5718.6819.92452.87--
P/FCF Ratio
--19.34---
P/OCF Ratio
--18.94---
EV/Sales Ratio
43.1951.9912.6299.70--
EV/EBITDA Ratio
--19.57---
EV/EBIT Ratio
--19.93---
EV/FCF Ratio
--18.48---
Debt / Equity Ratio
0.530.530.534.530.590.87
Debt / EBITDA Ratio
--0.55---
Debt / FCF Ratio
--0.52---
Net Debt / Equity Ratio
-0.33-0.33-0.951.87-0.490.40
Net Debt / EBITDA Ratio
3.673.67-0.98-0.391.68-1.21
Net Debt / FCF Ratio
---0.93-0.411.56-0.74
Asset Turnover
--1.360.330.480.80
Inventory Turnover
--1.872.002.592.75
Quick Ratio
--2.990.521.730.62
Current Ratio
--3.190.741.940.90
Return on Equity (ROE)
-19.00%-19.00%183.64%-143.77%-44.62%-25.51%
Return on Assets (ROA)
--53.82%-28.74%-14.01%-10.00%
Return on Invested Capital (ROIC)
-15.01%-28.80%1077.87%-172.17%-70.10%-38.81%
Return on Capital Employed (ROCE)
--71.50%-211.60%-26.30%-33.20%
Earnings Yield
-0.94%-0.79%4.82%-1.39%--
FCF Yield
--5.17%-1.24%--
Payout Ratio
--1.03%---
Buyback Yield / Dilution
-3.20%-3.20%-0.14%-10.56%-1.38%-3.64%
Total Shareholder Return
-3.20%-3.20%-0.14%-10.56%-1.38%-3.64%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.